The global extruded protein crispies and inclusions market was valued...
Read MoreThe global medical device connectivity market was valued at USD 3.5 billion in 2025 and is projected to reach USD 22.89 billion by 2035, expanding at a CAGR of 23.2%. Medical device connectivity encompasses the hardware, software, and services enabling real-time bidirectional data exchange between clinical medical devices — patient monitors, infusion pumps, ventilators, imaging systems, wearable sensors, and implantable devices — and hospital information systems including electronic health records, clinical decision support platforms, and care coordination workflows. The market is structurally driven by regulatory mandates requiring healthcare interoperability, the clinical evidence demonstrating that connected device data reduces medication errors and adverse events, and the convergence of AI-powered analytics with real-time device data streams that creates clinical intelligence unavailable from either source alone.
Wireless technologies hold the dominant connectivity share, with Wi-Fi and cellular 5G increasingly serving as the primary transport layer for medical device data transmission within and beyond the hospital campus. HL7 FHIR (Fast Healthcare Interoperability Resources) has become the dominant connectivity standard following U.S. ONC regulations mandating FHIR API implementation by healthcare organisations — creating a structured commercial pull for FHIR-compatible medical device connectivity solutions. Cloud-based deployment is the fastest-growing deployment mode, as healthcare organisations migrate from on-premises integration engines to cloud-native connectivity platforms that enable scalable real-time device data aggregation across multi-site health systems.
What is the confirmed market size and growth trajectory for the global medical device connectivity market?
The market was valued at USD 3.5 billion in 2025 and is projected to grow at a CAGR of 23.2% to USD 22.89 billion by 2035. Medical device connectivity solutions hold the largest product and service revenue share. Wireless technologies dominate by connectivity type. HL7 FHIR is the fastest-growing connectivity standard. Cloud-based deployment is the fastest-growing deployment mode. Hospitals and surgical centres are the largest end-user segment. North America leads by revenue; Asia-Pacific is the fastest-growing region.
How does HL7 FHIR’s emergence as the mandated interoperability standard reshape medical device connectivity procurement?
The U.S. Office of the National Coordinator for Health Information Technology‘s 21st Century Cures Act implementation regulations mandate FHIR API access for EHR vendors and healthcare organisations — creating a regulatory compliance requirement that is directly driving FHIR-compatible medical device connectivity investment. FHIR’s RESTful API architecture enables medical device data to be queried and transmitted using the same web standards as modern software applications, eliminating the proprietary translation layers that made legacy HL7 v2 device connectivity expensive and time-consuming to implement.
What is driving wireless and 5G technologies as the dominant medical device connectivity architecture?
Clinical workflow mobility requirements — nurses managing patients across multiple rooms, mobile care teams moving through hospital environments — make wired LAN connectivity impractical for patient monitoring and portable device applications. Wi-Fi 6 and 5G cellular connectivity provide the throughput, latency, and security required for real-time clinical data transmission from patient monitoring devices, infusion pumps, and wearable sensors. 5G’s ultra-low latency of less than 1 millisecond additionally enables the real-time remote device monitoring and robotic-assisted procedure applications that Wi-Fi’s variable latency cannot reliably support.
How does clinical workflow automation drive the highest-value medical device connectivity application?
Clinical workflow automation — using connected medical device data to automatically trigger nurse alerts, update medication administration records, populate EHR flowsheets, and escalate deteriorating patient notifications to rapid response teams — is the highest-value application because it directly reduces preventable adverse events. Closed-loop medication management, where infusion pump connectivity to EHR drug libraries automatically validates programmed doses against ordered medications, has been shown in clinical literature to reduce medication errors by 60% to 80% — the most commercially compelling patient safety ROI available from medical device connectivity investment.
What is the commercial significance of home healthcare settings as the fastest-growing end-user segment?
Home healthcare connectivity — where wearable and consumer-grade medical devices transmit patient vital signs, glucose readings, cardiac rhythm data, and medication adherence information to clinical monitoring platforms — is the fastest-growing end-user segment because it extends clinical monitoring beyond the hospital to the 90% of a patient’s life not spent in a clinical facility. Remote patient monitoring connectivity programmes have demonstrated 20% to 38% reductions in hospital readmission rates for chronic disease populations in clinical studies, creating an economically self-justifying investment case for health systems operating under value-based care reimbursement models.
How does the DICOM standard govern imaging system connectivity and what is its commercial significance?
DICOM (Digital Imaging and Communications in Medicine) is the universally adopted standard governing how imaging devices — MRI, CT, ultrasound, X-ray, and PET systems — transmit, store, and display medical images and associated metadata. Every commercially deployed imaging system from GE HealthCare, Philips Healthcare, and Siemens Healthineers produces DICOM-compliant output as a fundamental product requirement. The integration of DICOM-compliant imaging connectivity with FHIR-based clinical data platforms is the primary technical challenge driving enterprise imaging connectivity investment — and GE HealthCare’s USD 2.3 billion acquisition of Intelerad specifically targets the SaaS-based outpatient imaging workflow connectivity gap.
Key Players: Baxter International Inc. (NYSE: BAX), GE HealthCare Technologies (NASDAQ: GEHC), Philips Healthcare (Koninklijke Philips N.V.), Masimo Corporation (NASDAQ: MASI), Medtronic plc (NYSE: MDT), Cisco Systems (Healthcare Networking), Oracle Health, Cerner (Oracle), Epic Systems Corporation, Capsule Technologies (Nuvolo), Drägerwerk AG, Intelerad Medical Systems (GE HealthCare), Microsoft Azure Health, and Qualcomm Life
Recent Developments
The medical device connectivity market’s 23.2% CAGR through 2035 is driven by regulatory mandate, clinical safety evidence, and the emergence of AI-powered clinical intelligence that converts connected device data from operational infrastructure into clinical decision support. Baxter’s USD 1.911 billion Care and Connectivity Solutions revenue growing 5% annually confirms that established medical device companies are capturing connectivity platform revenue alongside device hardware. GE HealthCare’s USD 2.3 billion Intelerad acquisition documents the strategic priority that market leaders place on expanding connected imaging ecosystems into ambulatory and outpatient settings — the fastest-growing end-user segment. The market’s most commercially consequential variable is the pace of FHIR mandate implementation: as U.S. ONC compliance deadlines convert FHIR API implementation from aspirational to legally required, the volume of FHIR-compatible medical device connectivity procurement will accelerate proportionally — making regulatory compliance the most reliable commercial demand driver through 2030.
Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.
The global extruded protein crispies and inclusions market was valued...
Read MoreThe global ultrasound wound debridement devices market was valued at...
Read MoreThe global skin care products market was valued at USD...
Read MoreWhatsApp us